UF Receives $776.2 Million for Research in 2019
The University of Florida received $776.2 million in research funding in fiscal year 2019. About 68 percent of UF’s total funding came from the federal government, which awarded $526.8 million. Another $41.2 million came from the state, along with $54.4 million from industry and $99.1 million from foundations and non-profit organizations. “In 2018, we had […]
Virtual Humans Boost Mental Health Recovery
Benjamin Lok, a professor in the computer and information science and engineering department at the University of Florida, has been studying applications of virtual humans for two decades. His research has led to the creation of dozens of virtual characters that appear in 1,500 different programs around the world and wrack up over a million […]
Dr. Schmidt Elected Fellow of the International Academy of Medical and Biological Engineering
The International Academy of Medical and Biological Engineering has elected Dr. Christine Schmidt, professor, J. Crayton Pruitt Family Chair and Department Chair, as a Fellow of IAMBE. According to IAMBE, this honor recognizes her distinguished contribution to and leadership in the field of medical and biological engineering at an international level. Schmidt has many notable […]
Florida Citrus: Great Strides in Fight Against HLB
The Florida citrus industry has suffered some setbacks over the last few years, primarily due to the scourge of citrus greening or Huanglongbing (HLB). The good news is that researchers have made great strides in their fight against the disease, and many groves seem to be on the rebound. This year’s citrus harvest was pretty […]
Startup CEO Discusses Business Growth After Receiving Funding
UF startup Peerfit founder and CEO Ed Buckley gained a lot of traction with his business after receiving investment funding and coaching from organizations like Florida Funders. Peerfit promotes corporate wellness by giving the workforce access to exercise classes and programs through an interactive tech platform. The company grew from just four employees to more […]
Morphogenesis, Inc. Is Developing a Cell and Gene Therapy Focusing on a Cancer Vaccine Immunotherapy That Uses the Body’s Own Immune System to Kill Solid Tumors
Dr. Patricia Lawman, CEO and co-founder of UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, talks about the company, their projects – current and future – and the challenges she and her team have to face while developing cell and gene therapy technologies. “We are currently focusing on our cancer vaccine. This […]
UF Professor Earns American Psychological Association Award
University of Florida professor of food science and human nutrition, Dr. Linda Bartoshuk, is savoring some recognition for her contributions to the psychological study of human taste perception. Bartoshuk is among three 2019 recipients of the award for Distinguished Scientific Contributions from the American Psychological Association. Learn more about UF Professor Earns American Psychological Association […]
Jim Bowie Joins UF Innovate | The Hub as Associate Director
On August 12, UF Innovate | The Hub will have two celebrities at its helm. Jim Bowie, a descendent of the legendary Jim Bowie (think Battle of the Alamo and the Bowie knife), joins Hub Director Mark Long, an Elvis Tribute Artist and fearless leader of Incubation Services at the University of Florida. Of course, […]
Researchers Identify Prime Compound Candidates for New Room Temperature Semiconductor Radiation Detectors
Nuclear power plants can withstand most inclement weather and do not emit harmful greenhouse gases. However, trafficking of nuclear materials to furnish them with fuel remains a serious issue as security technology continues to be developed. Two physicists working out of the University of Florida and Pacific Northwest National Laboratory, Paul Johns and Juan Nino, […]
Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) Exhibited Potent Anti-Fibrotic Activity in NASH and CKD Studies
Algernon Pharmaceuticals Inc., formerly known as Breathtec, a UF startup, is pleased to report that its lead drugs for non-alcoholic steatohepatitis (NASH) and chronic kidney disease (CKD) Bemethyl (NP-135) and Bromantane (NP-160), exhibited highly statistically significant anti-fibrotic activity and outperformed known anti-fibrotic agents Telmisartan and Cenicriviroc. “We are planning off-label phase II clinical trials for […]